WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001030316) TRANSDERMAL DRUG DELIVERY DEVICES COMPRISING (R)-(Z)-1-AZABICYCLO(2.2.1)HEPTAN-3-ONE, 0-(3(3-METHOXYPHENYL)-2-PROPYNYL)OXIME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/030316    International Application No.:    PCT/US2000/029702
Publication Date: 03.05.2001 International Filing Date: 27.10.2000
Chapter 2 Demand Filed:    18.05.2001    
IPC:
A61K 9/70 (2006.01), A61K 31/439 (2006.01)
Applicants: 3M INNOVATIVE PROPERTIES COMPANY [US/US]; 3M Center, Post Office Box 33427, Saint Paul, MN 55133-3427 (US)
Inventors: DREYER, Steve J.; (US)
Agent: HOWARD, MarySusan; Office of Intellectual Property Counsel, Post Office Box 33427, Saint Paul, MN 55133-3427 (US).
VOSSIUS & PARTNER; Patentanwälte, P.O. Box 86 07 67, 81634 München (DE)
Priority Data:
60/162,368 28.10.1999 US
09/697,532 26.10.2000 US
Title (EN) TRANSDERMAL DRUG DELIVERY DEVICES COMPRISING (R)-(Z)-1-AZABICYCLO(2.2.1)HEPTAN-3-ONE, 0-(3(3-METHOXYPHENYL)-2-PROPYNYL)OXIME
(FR) DISPOSITIFS D'ADMINISTRATION TRANSDERMIQUE DE MEDICAMENTS
Abstract: front page image
(EN)Systems and devices for the transdermal delivery of the compound (R)-(Z)-1-azabicyclo[2.2.1]heptan-3-one, 0-[3(3-methoxyphenyl)-2-propynyl]oxime are disclosed. These devices include a drug in adhesive reservoir layer and a skin contacting adhesive layer in which the skin contacting adhesive layer acts as a rate controlling membrane. These devices also include a drug in adhesive reservoir layer and a skin contacting adhesive, where a membrane is placed between the two adhesive layers. The compound is a muscarinic agonist, useful in the treatment of a variety of cognitive disorders, including Alzheimer's Disease.
(FR)L'invention concerne des systèmes et des dispositifs destinés à l'administration transdermique du composé (R)-(Z)-1-azabicyclo[2.2.1]heptane-3-one, O-[3(3-méthoxyphényl)-2-propynyl]oxime. Ces dispositifs comprennent un médicament contenu dans une couche réservoir adhésive, ainsi qu'une couche adhésive de contact avec la peau, ladite couche adhésive de contact avec la peau tenant lieu de membrane de régulation de débit. Ces dispositifs comprennent également une couche réservoir adhésive et une couche adhésive de contact avec la peau, une membrane étant placée entre ces deux couches adhésives. Le composé est un agoniste muscarinique utilisé dans le traitement d'une pluralité de troubles cognitifs, et notamment de la maladie d'Alzheimer.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)